+43.4%
NVTS vs BBIO
+154.4%
-111.0%
-80.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +4.3% | -0.1% | +4.4% | +4.3% |
| 7D | -1.4% | -3.2% | +1.8% | -0.1% |
| 30D | -16.5% | -13.6% | -2.9% | -11.5% |
| 3M | -47.6% | +7.2% | -54.9% | -49.6% |
| 6M | +7.3% | +1.5% | +5.8% | +6.0% |
| YTD | +62.9% | -5.3% | +68.2% | +63.8% |
| 1Y | +91.3% | +37.7% | +53.6% | +65.8% |
| 3Y | +43.4% | +153.9% | -110.5% | -9.1% |
| All | +43.4% | +154.4% | -111.0% | -9.1% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling